These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 8596953

  • 1. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A.
    Bevec D, Jaksche H, Oft M, Wöhl T, Himmelspach M, Pacher A, Schebesta M, Koettnitz K, Dobrovnik M, Csonga R, Lottspeich F, Hauber J.
    Science; 1996 Mar 29; 271(5257):1858-60. PubMed ID: 8596953
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
    Liu YP, Nemeroff M, Yan YP, Chen KY.
    Biol Signals; 1997 Mar 29; 6(3):166-74. PubMed ID: 9285100
    [Abstract] [Full Text] [Related]

  • 6. Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.
    Katahira J, Ishizaki T, Sakai H, Adachi A, Yamamoto K, Shida H.
    J Virol; 1995 May 29; 69(5):3125-33. PubMed ID: 7707541
    [Abstract] [Full Text] [Related]

  • 7. Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin.
    Hofmann W, Reichart B, Ewald A, Müller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC.
    J Cell Biol; 2001 Mar 05; 152(5):895-910. PubMed ID: 11238447
    [Abstract] [Full Text] [Related]

  • 8. The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2.
    Steinkasserer A, Jones T, Sheer D, Koettnitz K, Hauber J, Bevec D.
    Genomics; 1995 Feb 10; 25(3):749-52. PubMed ID: 7759117
    [Abstract] [Full Text] [Related]

  • 9. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.
    Ruhl M, Himmelspach M, Bahr GM, Hammerschmid F, Jaksche H, Wolff B, Aschauer H, Farrington GK, Probst H, Bevec D.
    J Cell Biol; 1993 Dec 10; 123(6 Pt 1):1309-20. PubMed ID: 8253832
    [Abstract] [Full Text] [Related]

  • 10. Effects of inhibitors of RNA and protein synthesis on the subcellular distribution of the eukaryotic translation initiation factor, eIF-5A, and the HIV-1 Rev protein.
    Shi XP, Yin KC, Waxman L.
    Biol Signals; 1997 Dec 10; 6(3):143-9. PubMed ID: 9285097
    [Abstract] [Full Text] [Related]

  • 11. Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study.
    Junker U, Bevec D, Barske C, Kalfoglou C, Escaich S, Dobrovnik M, Hauber J, Böhnlein E.
    Hum Gene Ther; 1996 Oct 01; 7(15):1861-9. PubMed ID: 8894678
    [Abstract] [Full Text] [Related]

  • 12. Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta.
    Henderson BR, Percipalle P.
    J Mol Biol; 1997 Dec 19; 274(5):693-707. PubMed ID: 9405152
    [Abstract] [Full Text] [Related]

  • 13. Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.
    Bevec D, Klier H, Holter W, Tschachler E, Valent P, Lottspeich F, Baumruker T, Hauber J.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):10829-33. PubMed ID: 7971969
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1.
    Rosorius O, Reichart B, Krätzer F, Heger P, Dabauvalle MC, Hauber J.
    J Cell Sci; 1999 Jul 08; 112 ( Pt 14)():2369-80. PubMed ID: 10381392
    [Abstract] [Full Text] [Related]

  • 18. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
    Bogerd H, Greene WC.
    J Virol; 1993 May 08; 67(5):2496-502. PubMed ID: 8474155
    [Abstract] [Full Text] [Related]

  • 19. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface.
    Thomas SL, Oft M, Jaksche H, Casari G, Heger P, Dobrovnik M, Bevec D, Hauber J.
    J Virol; 1998 Apr 08; 72(4):2935-44. PubMed ID: 9525614
    [Abstract] [Full Text] [Related]

  • 20. The subcellular distribution of eukaryotic translation initiation factor, eIF-5A, in cultured cells.
    Shi XP, Yin KC, Zimolo ZA, Stern AM, Waxman L.
    Exp Cell Res; 1996 Jun 15; 225(2):348-56. PubMed ID: 8660923
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.